Vaxart, Inc. Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31)
Vaxart, Inc. (VXRT) reported Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) of $0 for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions · last filed 2015-11-06
- Vaxart, Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for the quarter ending 2015-09-30 was $0.00.
- Vaxart, Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for the quarter ending 2015-03-31 was $0.00.
- Vaxart, Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for the quarter ending 2014-12-31 was $0.00.
- Vaxart, Inc. employee service share-based compensation, tax benefit realized from exercise of stock options (deprecated 2017-01-31) for fiscal 2015 was $0.00.
| Period end | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 3 month | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 6 month | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) 12 month |
|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-06 | ||
| 2015-06-30 | $0.00 10-K · filed 2015-09-11 | ||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-05-08 | |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |